Effect of Vitamin D Supplementation in Young South African Children Hospitalized With Acute Lower Respiratory Infection

NCT02054182 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 320

Last updated 2014-02-04

No results posted yet for this study

Summary

The purpose of this study is to determine whether vitamin D supplements given to children aged 1 month to 5 years, hospitalized with acute lower respiratory tract infection will improve symptoms and reduce the duration of hospitalization.

Conditions

  • Acute Lower Respiratory Tract Infection
  • Pneumonia
  • Bronchiolitis

Interventions

DRUG

Vitamin D

Vitamin D 2 500 IU daily from enrolment (within 24 hours of hospitalization) until discharge from hospital

Sponsors & Collaborators

  • University of Limpopo

    lead OTHER

Principal Investigators

  • Siyazi Mda, MBChB, PhD · Univeristy of Limpopo, Medunsa Campus

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2014-11-30
Completion
2015-01-31

Countries

  • South Africa

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02054182 on ClinicalTrials.gov